Catalyst Wire Dossier Catalyst Wire Dossier

IvabRadine Hemisulfate Sustained-release Tablets

ivabradine hemisulfate sustained-release · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IvabRadine Hemisulfate Sustained-release Tablets, covering 2014-07-11 to 2014-07-11. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets (FIRST) [Phase 2, Phase 3]

See pricing